All In Biotech

Drug Trial Radar · NCT06443944

An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG

An Expanded Access Program of Cretostimogene Grenadenorepvec in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)

Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Available

Status

Available

Enrollment

Not stated

Start

Not stated

Primary completion

Not stated

Sponsor

Lead sponsor
CG Oncology, Inc.Industry
Sponsor type
Industry
First posted
Jun 5, 2024

More drug trials from this sponsor

Design

Study type
Expanded access
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

This is an open-label, expanded access trial designed to provide access to cretostimogene in patients with NMIBC (specifically CIS with or without HG Ta/T1) unresponsive to BCG.

Conditions

  • Non-Muscle Invasive Bladder Cancer
  • Urothelial Carcinoma
  • Urologic Cancer
  • Bladder Cancer

Interventions

  • Cretostimogene GrenadenorepvecDrug

    Engineered Oncolytic Adenovirus

  • n-dodecyl-B-D-maltosideOther

    Transduction-enhancing agent

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

27 sites in 1 country. Site status is shown where the registry gives one.

  • Banner MD Anderson Cancer Center

    Gilbert, Arizona · Available

  • Michael G. Oefelein Clinical Trials

    Bakersfield, California · Available

  • University of Southern California / Norris Comprehensive Cancer Center

    Los Angeles, California · Available

  • McR, Llc.

    Murrieta, California · Available

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia · Available

  • Advanced Urology Institute

    Daytona Beach, Florida · Available

  • Lakeland Regional Medical Center - Hollis Cancer Center

    Lakeland, Florida · Available

  • Advanced Urology Institute

    Largo, Florida · Available

  • Emory University

    Atlanta, Georgia · Available

  • Uropartners c/o Associated Urological Specialists

    Chicago Ridge, Illinois · Available

  • UroPartners, LLC

    Glenview, Illinois · Available

  • Urologic Specialists of Northwest Indiana

    Merrillville, Indiana · Available

  • Urology Center of Iowa Research

    Clive, Iowa · Available

  • Brigham and Women's Hospital

    Boston, Massachusetts · Available

  • Michigan Institute of Urology, PC

    Troy, Michigan · Available

  • Mayo Clinic Rochester

    Rochester, Minnesota · Available

  • The Urology Group, P.C.

    Southaven, Mississippi · Available

  • Urology Nevada

    Reno, Nevada · Available

  • Integrated Medical Professionals, PLLC

    New York, New York · Available

  • MidLantic Urology

    Bala-Cynwyd, Pennsylvania · Available

  • Lowcountry Urology Clinics, PA

    North Charleston, South Carolina · Available

  • Urology Partners of North Texas Research Institute

    Arlington, Texas · Available

  • Urology Clinics of North Texas

    Dallas, Texas · Available

  • Urology San Antonio, PA dba USA Clinical Trials

    San Antonio, Texas · Available

  • Digestive Health Research of North Texas

    Wichita Falls, Texas · Available

  • University of Washington Medical Center

    Seattle, Washington · Available

  • Spokane Urology

    Spokane, Washington · Available

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.